Sheena N Smith

Title: Sheena N Smith: Innovator in T Cell Receptor Engineering

Introduction

Sheena N Smith is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of immunology, particularly in the engineering of T cell receptors (TCRs). With a total of 3 patents, her work focuses on enhancing the specificity and affinity of TCRs for targeted therapies.

Latest Patents

One of her latest patents involves the engineering of T cell receptors for the use as scaffolds in vitro. This patent outlines a method for isolating TCRs with de novo binding to specific peptide-major histocompatibility complex (MHC) products. The process includes mutagenizing a TCR protein coding sequence to create a library of mutants, followed by selection using directed evolution techniques. Another notable patent details the development of high-affinity TCRs that target the WT1 antigen. These TCRs are engineered through mutational libraries and can be utilized in various therapeutic settings, including adoptive T cell therapy.

Career Highlights

Sheena has worked at the University of Illinois, where she has been able to apply her innovative ideas in a collaborative research environment. Her work has not only advanced the understanding of T cell biology but has also opened new avenues for cancer immunotherapy.

Collaborations

Throughout her career, Sheena has collaborated with notable researchers such as David M Kranz and Daniel T Harris. These collaborations have enriched her research and contributed to the successful development of her patented technologies.

Conclusion

Sheena N Smith is a trailblazer in the field of T cell receptor engineering, with a focus on creating innovative solutions for targeted immunotherapies. Her contributions are paving the way for advancements in cancer treatment and immunology.